mRNA regulations
mRNA Regulatory Landscape
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA32Sep 15, 2026
Development CDMO
The Case for Earlier CDMO Involvement in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-02Sep 2, 2026
Small molecules
Small Molecule API Regulatory Trends
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA51Aug 27, 2026
Potency Assurance
Why Potency Cannot Be Reduced to a Release Assay in Active Immunotherapy Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-26-PA-16Aug 24, 2026
Preparedness
Preparing Manufacturing Networks for the Next Pandemic
Pharma's Almanac
PAO-08-26-PA-14Aug 20, 2026
Supply Chain
Supply Chain Resilience in 2026: Any Progress?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-15Aug 19, 2026
Device Integration
Medical Device Integration: Exploring the Benefits and Challenges to Effective Implementation
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-06Aug 10, 2026
Stem Cells
Stem Cell Therapies: Close to Transforming Promise into Real Patient Outcomes
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-07-26-PA-11Jul 22, 2026
Rare Cancer CGT
Developing Cell and Gene Therapies for Rare Oncology Applications
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-26-PA-10Jul 16, 2026
Data Integrity
Data Integrity: Drivers, Challenges, and Key Program Elements
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-26-PA-20Jun 23, 2026
Adaptive Trials
Designing for Change: Adaptive Clinical Trials and the Evolving Path to Regulatory Acceptance
Pharma's Almanac
PAO-06-26-PA-12Jun 19, 2026
Personalized
Regulatory Innovation for a More Personalized Era of Medicine
Pharma's Almanac
PAO-06-26-PA-11Jun 18, 2026
Expedited Pathways
Accelerated Pathways: Are They Delivering on Their Promise?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-10Jun 17, 2026
Clinical Evidence
Rethinking Clinical Evidence Requirements in Rare Diseases
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-09Jun 16, 2026
Supply Chain
Outsourcing, Fragmentation, and the New Supply Chain Resilience Challenge
Pharma's Almanac
PAO-06-26-PA-07Jun 12, 2026
Outsourcing
The Hidden Operational Costs of Multi-Vendor Outsourcing Models
Pharma's Almanac
PAO-06-26-PA-06Jun 11, 2026
AI in Manufacturing
Validating and Governing AI in GMP Manufacturing
Pharma's Almanac
PAO-06-26-PA-03Jun 4, 2026
AI Data Integrity
Data Integrity in the Age of AI-Assisted Manufacturing
Pharma's Almanac
PAO-06-26-PA-02Jun 3, 2026
RNA
Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate
April Stanley, MS MBA; Cynthia A. Challener, Ph.D.
Nice Insight
PAO-03-25-NI-06Mar 26, 2025
Global Trials
Clinical Trials Without Borders: The Evolution of Global Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-21Mar 14, 2025